CYTOGEN’s ONCOSCINT RECEIVES ADVISORY COMMITTEE CLEARANCE FOR DIAGNOSIS OF OVARIAN AND COLORECTAL CANCER; MAY BE FIRST MAb-BASED TUMOR IMAGING AGENT